| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 03/29/2007 | US20070072878 intravenous or oral administration of viricides against the Flaviviridae family of viruses; e.g. 2-[5(6)-Amidino-2-benzimidazoyl]-5-(4-nitrophenyl)furan |
| 03/29/2007 | US20070072877 intravenous or oral administration of viricides against the Flaviviridae family of viruses; e.g. 2,5-Bis(2-methyl-4-N,N'-di-BOCguanidinophenyl)furan |
| 03/29/2007 | US20070072874 Aminoheteroaryl compounds as protein kinase inhibitors |
| 03/29/2007 | US20070072869 CERTAIN GLYCINE DERIVATIVES AS FACTOR Xa INHIBITORS FOR USE IN THE TREATMENT OF THROMBOTIC DISORDERS |
| 03/29/2007 | US20070072868 Novel synthesis of gatifloxacin |
| 03/29/2007 | US20070072866 that inhibit the metabolic activity of the enzyme glycogen synthase kinase 3 beta (GSK-3 beta), which is believed to cause the neurodegeneration that results in diseases of the central nervous system; enzyme inhibitors |
| 03/29/2007 | US20070072860 Apoptosis promoters |
| 03/29/2007 | US20070072857 Treating sleep disorders insomnia; 1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(4-chloro-phenyl)-urea; restless leg syndrome, cardiovascular disorders, reducing blood clot |
| 03/29/2007 | US20070072855 5-(5-Chloro-2,4-dihydroxy-phenyl)-4-(4-methoxy-phenyl)-2H-pyrazole-3-carboxylic acid, for example; for treatment of diseases which are mediated by excessive or inappropriate HSP90 activity, such as cancers |
| 03/29/2007 | US20070072853 Benzimidazole derivatives compositions containing them, preparation thereof and uses thereof |
| 03/29/2007 | US20070072850 Pesticides |
| 03/29/2007 | US20070072847 -(4-Hydroxy-3,5-dimethyl-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate; headaches; non-insulin dependent diabetes; antidiabetic agents; cardiovascular/nervous system disorders; antiinflammatory agents |
| 03/29/2007 | US20070072842 6-Alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adpribose) polymerase inhibitors |
| 03/29/2007 | US20070072812 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones |
| 03/29/2007 | CA2619068A1 Imidazole compounds for the treatment of neurological disorders |
| 03/28/2007 | EP1767534A1 Drug for treating or preventing duplication of hypertension with serum hyperuricemia and/or hypercholesterolemia |
| 03/28/2007 | EP1767525A1 Guanidino compounds as melanocortin-4 receptor (MC4-R) agonists |
| 03/28/2007 | EP1765818A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use |
| 03/28/2007 | EP1765813A1 Substituted indazoles, compositions containing same, preparation and use |
| 03/28/2007 | EP1765795A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 03/28/2007 | EP1765791A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
| 03/28/2007 | EP1765790A1 Azine-carboxamides as anti-cancer agent |
| 03/28/2007 | EP1765788A2 3-aminoindazole derivatives and their use for the treatment of sgk-associated diseases |
| 03/28/2007 | EP1765409A2 Conjugates of antibody and duocarmycin derivatives as antitumor agents |
| 03/28/2007 | EP1765335A2 Pyrazole amide derivatives, compositions containing such compounds and methods of use |
| 03/28/2007 | EP1470136B1 Method for the separation of acids from chemical reaction mixtures by means of ionic fluids |
| 03/28/2007 | EP1228071B1 Pharmaceutically active isoindoline derivatives |
| 03/28/2007 | CN1938299A Thioamide derivatives as progesterone receptor modulators |
| 03/28/2007 | CN1938298A Methods for minimizing thioamide impurities |
| 03/28/2007 | CN1938296A Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists |
| 03/28/2007 | CN1938295A Imidazolo-5-yl-anilinopyrimidines as agents for the inhibition of cell proliferation |
| 03/28/2007 | CN1938294A Novel pyrrolidine-3,4-dicarboxamide derivatives |
| 03/28/2007 | CN1938286A Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 03/28/2007 | CN1938283A Pyridazinones as antagonists of alpha4 integrins |
| 03/28/2007 | CN1938281A Ion channel modulators |
| 03/28/2007 | CN1938280A Thiourea compositions and uses thereof |
| 03/28/2007 | CN1938273A Tetrahydrocarbazoles and derivatives |
| 03/28/2007 | CN1938269A Prolinyl derivatives for treating thrombosis |
| 03/28/2007 | CN1938031A Biaryl substituted pyrazinones as sodium channel blockers |
| 03/28/2007 | CN1938022A Ion channel modulators |
| 03/28/2007 | CN1938021A Ion channel modulators |
| 03/28/2007 | CN1938020A Ion channel modulators |
| 03/28/2007 | CN1935805A Pyrimidine derivative compound and its preparing method |
| 03/28/2007 | CN1935793A Process for producing substituted aniline compound |
| 03/28/2007 | CN1935792A Process for producing substituted aniline compound |
| 03/28/2007 | CN1935780A Process for producing substituted aniline compound |
| 03/28/2007 | CN1307173C Pyrimidineamines as angiogenesis modulators |
| 03/28/2007 | CN1307161C Substituted dihydro 3-hylo-1H-pyrazoloe-5-carboxylates their prepn. and use |
| 03/28/2007 | CN1307155C Deltal-pyrrolines used as pesticides |
| 03/28/2007 | CN1306935C Vasopressin antagonist and oxytocin antagonist |
| 03/27/2007 | US7196201 For therapy and prophylaxis of metabolic disorders, gastrointestinal disorders, viral disorders, inflammatory disorders, diabetes, obesity, hyperlipidemia, dermatological or mucous membrane disorders, psoriasis, intestinal distress, constipation, autoimmune disorders, encephalomyelitis |
| 03/27/2007 | US7196194 for color photography |
| 03/27/2007 | US7196193 Reacting 2-(11H-dibenz[b,e]azepin-6-ylmethyl)-1H-isoindole-1,3(2H)-dione with a metal hydride or a metal hydride complex (sodium borohydride); antiallergic and antihistamine; hydrazine free |
| 03/27/2007 | US7196110 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents |
| 03/27/2007 | US7196109 Piperidine-1-carboxylic acid (6,7-difluoro-5-phenyl-1H-indazol-3-yl)amide; especially for treating neurodegenerative diseases; kinase inhibitor |
| 03/27/2007 | US7196095 anti-protoazoal; poultry feed; therapy for cytokine mediated disease i.e. osteoarthritis, cerebral malaria, chronic pulmonary inflammatory disease, silicosis, pulmonary sarcosis, bone resorption diseases, reperfusion injury, graft v. host rejection |
| 03/27/2007 | US7196087 useful for modulating the 5-HT6 receptor, the 5-HT2A receptor, or both; useful in the treatment of certain CNS disorders such as Parkinson's disease, Huntington's disease, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's |
| 03/27/2007 | US7196085 Phthalazinone derivatives |
| 03/27/2007 | US7195751 For the determination of an analyte or analytes such as proteins, peptides, nucleic acids, carbohydrates, lipids, steroids and small molecules by mass analysis |
| 03/27/2007 | CA2251820C Substituted benzylamines and their use for the treatment of depression |
| 03/27/2007 | CA2208018C Sulfonamides |
| 03/22/2007 | WO2007033366A2 Biphenyl-pyrazolecarboxamide compounds |
| 03/22/2007 | WO2007032833A1 Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/22/2007 | WO2007032536A1 Histamine h3 agonist for use as therapeutic agent for lipid/glucose metabolic disorder |
| 03/22/2007 | WO2007032371A1 Oxindole derivative as feeding control agent |
| 03/22/2007 | WO2007031860A1 Indane substituted benzimidazoles and their use as acid pump inhibitors |
| 03/22/2007 | WO2007031529A1 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity |
| 03/22/2007 | WO2007031429A1 Novel heterobicyclic derivatives useful as inhibitors of liver carnitine palmitoyl transferase |
| 03/22/2007 | WO2007030848A2 Non-fluorescent chlorophyll catabolites |
| 03/22/2007 | WO2007006926A3 Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors |
| 03/22/2007 | WO2007004041A3 New compounds and their pharmaceutical use |
| 03/22/2007 | WO2006129120A9 Benzotriazepinone derivatives |
| 03/22/2007 | WO2006113468A3 Compositions of novel opioid compounds and method of use thereof |
| 03/22/2007 | WO2006060122A3 Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
| 03/22/2007 | US20070066834 Ionic liquids |
| 03/22/2007 | US20070066828 contacting pyridines or pyrimidines monomer with a particlulate catalyst containing metal or alloy (e.g. magnesium or alloy substrate) having a second reduced metal or alloy ( Ni, Cu, Co etc.) coated on the substrate to form dimer ( bi-pyridine) or polymer |
| 03/22/2007 | US20070066820 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 03/22/2007 | US20070066700 Piperazine-based sensitisers |
| 03/22/2007 | US20070066672 Benzimidazole derivatives and use thereof as peptide deformylase inhibitors |
| 03/22/2007 | US20070066670 Substituted benzimidazoles and their use for inducing apoptosis |
| 03/22/2007 | US20070066660 e.g. (5-chloro-6-trifluoromethyl-1H-benzimidazol-2-yl)[4-(pyridin-4-yloxy) phenyl]amine; tyrosine kinases receptor (such as TIE-2) inhibitor; anticarcinogenic, antiinflammatory agent; autoimmune diseases; rheumatoid arthritis, psoriasis, contact dermatitis, leukaemia, lung adenocarcinoma |
| 03/22/2007 | US20070066657 Biphenyl-pyrazolecarboxamide compounds |
| 03/22/2007 | US20070066651 Pyrazoline derivatives useful for the treatment of cancer |
| 03/22/2007 | US20070066636 Polymorphs of tartrate salt of 2-[2-(3-(r)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6h-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor |
| 03/22/2007 | US20070066635 Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
| 03/22/2007 | US20070066634 Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites |
| 03/22/2007 | US20070066633 Angiogenesis inhibitor; anticancer agents; antiarthritic agents; psoriasis |
| 03/22/2007 | US20070066626 Compounds, compositions and methods |
| 03/22/2007 | US20070066624 Chemokine receptor binding compounds |
| 03/22/2007 | US20070066623 Entry inhibitors of the hiv virus |
| 03/22/2007 | US20070066622 2-(3-Phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses |
| 03/22/2007 | US20070066618 Use of EP4 Receptor Ligands in the Treatment of IL-6 Involved Diseases |
| 03/22/2007 | US20070066613 (S)-2-[2-(3,5-Difluoro-phenyl)-acetylamino]-pentanoic acid {1-[2-(3-ethoxy-propylamino) -ethyl]-1H-imidazol-4-yl}-amide, having beta-amyloid peptide production inhibitory activity, used for the treatment of neurodegenerative disorders such as Alzheimer's disease |
| 03/22/2007 | US20070066607 5-[R-2-(1S,2S-2-Cyclohexylcyclopentylamino)-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one, useful for treating conditions that are prevented or alleviated by activation of the adrenergic recptors |
| 03/22/2007 | US20070066606 Benzylbenzimidazolyl derivatives |
| 03/22/2007 | US20070066599 New compounds |
| 03/22/2007 | US20070066598 Compounds |
| 03/22/2007 | US20070066596 Pesticidal 5-substituted-oxalkylamino-1-arylpyrazole derivatives |
| 03/22/2007 | US20070066586 Aniline derivatives |
| 03/22/2007 | US20070066585 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |